Brief: Bio-Works Technologies Confirms Three New Orders
Aug 15 (Reuters) - Bio-Works Technologies AB BIOWKS.ST :
* CONFIRMS THREE NEW ORDERS OF WORKBEADS AFFIMAB FOR USE IN
ANTIBODY PRODUCTION
* TOTAL ORDER VALUE AMOUNTS TO SEK 8.1 MILLION
* ORDERS WILL BE DELIVERED AS SEPARATE DELIVERIES IN SECOND
HALF
OF 2022 AND THE FIRST QUARTER OF 2023
Source text for Eikon: ID:nMFN7xPDX9
Further company coverage: BIOWKS.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))